Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ironwood Pharmaceuti (NQ: IRWD ) 4.010 -0.290 (-6.74%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Ironwood Pharmaceuti < Previous 1 2 3 Next > IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 August 08, 2024 IRWD stock results show that Ironwood Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday June 21, 2024 Via Benzinga IRWD Stock Earnings: Ironwood Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 IRWD stock results show that Ironwood Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 09, 2024 Via Benzinga Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks April 30, 2024 As the stock market corrects, focusing on stable investments is crucial. This is why you should steer clear of these biotech stocks to avoid. Via InvestorPlace Earnings Scheduled For February 15, 2024 February 15, 2024 Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. Via Benzinga A Preview Of Ironwood Pharmaceuticals's Earnings February 14, 2024 Via Benzinga Chart Of The Day: Ironwood Pharma - Gastrointestinal Products February 13, 2024 Via Talk Markets Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session May 09, 2024 Via Benzinga Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March March 07, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga Earnings Preview For Ironwood Pharmaceuticals August 07, 2023 Via Benzinga It’s Time! 3 Failing Biotech Stocks to Sell Right Now March 05, 2024 The biotech industry offers investors unique investment opportunities but these three are biotechs to sell. Via InvestorPlace Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 29, 2024 Via Benzinga Stocks Mixed, Headed For Monthly Wins February 29, 2024 In what appears to be a theme this week, stocks are hesitant midday as investors unpack this morning's jobs and inflation data. Via Talk Markets Topics Economy Exposures Interest Rates Why Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday? February 29, 2024 Ironwood Pharmaceuticals' SBS-IF treatment Apraglutide's Phase 3 trial met primary endpoints, reducing PS dependency by 25.5% vs. placebo, but misses on two key secondary endpoints. Via Benzinga Nasdaq Gains 100 Points Following PCE Data February 29, 2024 U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.07% to 38,923.11 while the... Via Benzinga Topics Stocks Exposures US Equities PSNY Stock Alert: Polestar Makes Moves With Its Joint Venture February 29, 2024 Polestar stock is rising higher on Thursday as holders of PSNY shares react to an update for the company's Chinese joint venture. Via InvestorPlace Ironwood Pharmaceuticals Ran Up 32% Over Two Months — And Just Lost It All February 29, 2024 The company still plans to ask for approval of its short bowel syndrome treatment. Via Investor's Business Daily Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge February 29, 2024 Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 500, and small caps. Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today? February 29, 2024 Ironwood Pharmaceuticals stock is falling on Thursday with investors in IRWD unimpressed by its latest Phase III clinical trial results. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 29, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 29, 2024 It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning! Via InvestorPlace Top 4 Health Care Stocks You May Want To Dump In February February 15, 2024 As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 19, 2023 Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 September 28, 2023 Via Benzinga Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday September 19, 2023 U.S. stocks traded lower on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround June 12, 2023 Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned. Via The Motley Fool The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree June 02, 2023 Big Pharma is facing a patent cliff that could siphon off billions in revenue. Via Investor's Business Daily Why Ironwood Pharmaceuticals Stock Bumped Higher Today May 22, 2023 Investors indicated approval of the company's upcoming $1 billion asset purchase. Via The Motley Fool < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.